Frederic Becq

Title: Frederic Becq: Innovator in Cystic Fibrosis Treatment

Introduction

Frederic Becq is a notable inventor based in La Chapelle Montreuil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cystic fibrosis. With a total of 3 patents to his name, his work has the potential to impact many lives.

Latest Patents

Frederic Becq's latest patents include innovative compounds aimed at treating cystic fibrosis. One of his inventions relates to compounds of Formula (I) or their pharmaceutically acceptable enantiomers, salts, solvates, or prodrugs. This invention also details a process for manufacturing these compounds. Another significant patent involves the use of guanabenz and its derivatives for creating drugs that address cystic fibrosis and related diseases caused by protein deficiencies in cells. These derivatives correspond to a specific formula, wherein R can be hydrogen or a carbon chain, and the phenyl group includes two substituents or a pharmaceutically acceptable salt of these derivatives.

Career Highlights

Frederic Becq has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Poitiers. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Frederic has collaborated with notable colleagues, including Jean-Luc Decout and Isabelle Callebaut. Their combined efforts have furthered research in the field of cystic fibrosis treatment.

Conclusion

Frederic Becq's innovative work in developing compounds for cystic fibrosis treatment showcases his dedication to improving healthcare. His contributions through patents and collaborations highlight the importance of research in addressing critical health issues.